Cox regression models for quality adjusted survival analysis.

We develop a method for incorporating covariates as regressors in a quality adjusted survival analysis (Q-TWiST) using Cox's proportional hazards model. The standard Q-TWiST method assumes that patients progress through a series of health states which differ in quality of life. The Kaplan-Meier product limit method is used to estimate the mean duration of each state by estimating the survival curves for the health state transition times. These estimates provide the basis for quality adjusted survival analysis. In this paper, the survival curves are modelled using Cox's proportional hazards regression. Quality adjusted survival is estimated given sets of covariate values, allowing one to profile patients. The results are useful for investigating how prognostic factors affect treatment benefits in terms of quality of life. We give a brief review of the standard Q-TWiST method and illustrate the extended methodology with an example from the International Breast Cancer Study Group Trial V comparing short duration versus long duration chemotherapy in the treatment of node-positive breast cancer.

[1]  R. Gelber,et al.  Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group. , 1994, Biometrics.

[2]  Theodore Karrison,et al.  Restricted Mean Life with Adjustment for Covariates , 1987 .

[3]  R. Gelber,et al.  Quality adjusted survival analysis. , 1990, Statistics in medicine.

[4]  M. Schumacher,et al.  Assessment of quality of life in clinical trials. , 1991, Statistics in medicine.

[5]  D. Cox Regression Models and Life-Tables , 1972 .

[6]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[7]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[8]  A. Tsiatis A Large Sample Study of Cox's Regression Model , 1981 .

[9]  F. Cavalli,et al.  Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer , 1991 .

[10]  N. Breslow,et al.  A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship , 1974 .

[11]  L. J. Wei,et al.  Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .

[12]  M A Fischl,et al.  Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. , 1992, Annals of internal medicine.

[13]  David R. Cox,et al.  Quality‐Of‐Life Assessment: Can We Keep it Simple? , 1992 .

[14]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[15]  P Glasziou,et al.  Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.